Sarip, Haiba A.
HRN: 22 79 29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
MUPIROCIN 2%, 15G (TUBE)
05/23/2025
05/29/2025
TOPICAL
Apply Thin Coat
BID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes